Viking Global Investors LP Horizon Therapeutics Public LTD CO Transaction History

Viking Global Investors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $108 Million - $129 Million	-1,170,211 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $81.5 Million - $90.7 Million	-945,446 Reduced 44.69%	1,170,211 $110 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $111 Million - $148 Million	-1,547,219 Reduced 42.24%	2,115,657 $195 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $167 Million - $210 Million	2,489,132 Added 212.07%	3,662,876 $268 Million
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $16.4 Million - $23.8 Million	-297,675 Reduced 20.23%	1,173,744 $91.2 Million
Q2 2020 Aug 07, 2020	SELL	$30.2 - $56.98 $15.7 Million - $29.6 Million	-519,851 Reduced 26.11%	1,471,419 $81.8 Million
Q1 2020 May 13, 2020	BUY	$24.87 - $38.56 $49.5 Million - $76.8 Million	1,991,270 New	1,991,270 $59 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

Stay updated on Viking Global Investors LP with notifications on news.